Table 9 provides the efficacy results for Studies 5 and 6
As the cost of these medications comes down and more people recognize the long-term benefits of obesity treatment, we may start to see insurance companies changing their approach
Cell Signal 20:17151724 Oestreich EA, Wang H, Malik S, Kaproth-Joslin KA, Blaxall BC, Kelley GG, Dirksen RT, Smrcka AV (2007) Epac-mediated activation of phospholipase C plays a critical role in -adrenergic receptor-dependent enhancement of Ca 2+ mobilization in cardiac myocytes
Although some individuals may report positive effects anecdotally, these personal accounts do not replace medical evidence
GLP-1 RAs should replace metformin in the type 2 diabetes algorithm
These fatty obstructions can reduce or limit absorption, and may remain for weeks or months